New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
14:46 EDTMYGN, AZNFDA panel does not back accelerated approval of Astra cancer drug, Reuters says
An FDA advisory panel said existing data do not support accelerated approval of AstraZeneca's (AZN) ovarian cancer drug, olaparib, according to Reuters. Shares of Myriad Genetics (MYGN), which is seeking FDA approval for a companion diagnostic test for olaparib, are off their earlier highs following the headlines about the FDA panel decision. Reference Link
News For AZN;MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
06:24 EDTAZNAstraZeneca turning antibiotic R&D into separate subsidiary, Reuters reports
Subscribe for More Information
February 24, 2015
16:28 EDTMYGNMyriad Genetics board approves $200M increase in share buyback program
Subscribe for More Information
February 23, 2015
12:53 EDTAZNAnalysts debate potential for competing Salix takeover bid
Subscribe for More Information
07:55 EDTAZNJefferies says other bidders may emerge for Salix
Jefferies says it could envision other bidders emerging for Salix (SLXP) and points out recent media reports have suggested Shire (SHPG) and Endo (ENDP) have considered making a bid for the company. It lists AstraZeneca (AZN) and Takeda as others who could have possible interest in Salix. The firm believes Valeant (VRX) could afford to pay more for Salix should other bidders emerge.
February 20, 2015
07:23 EDTAZNAbbVie replaces Pfizer as top global pharma pick at Jefferies
Subscribe for More Information
07:08 EDTAZNAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 17, 2015
17:16 EDTAZNActavis confirms temporary injunction related to generic Pulmicort RESPULES
Subscribe for More Information
10:53 EDTMYGNScopia Capital reports 5.87% passive stake in Myriad Genetics
February 13, 2015
16:32 EDTAZNActavis launches generic Pulmicort RESPULES
Subscribe for More Information
08:19 EDTAZNAckman noncommittal on McDonald's rumors, Bloomberg reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use